| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 08/30/2005 | US6936622 they are phosphodiesterase (PDE) inhibitors useful for treament of allergic rhinitis, crohn's disease, ulcerative colitis, rheumatoid arthritis, bronchitis, bronchial asthma, COPD, ARDS, psoriasis, eczema, and combination thereof thereof. |
| 08/30/2005 | US6936612 2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| 08/30/2005 | US6936611 Serine protease inhibitors |
| 08/30/2005 | US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 08/30/2005 | US6936280 Method for preparing a composition by extraction of mother-of-pearl, composition obtained by said method and use thereof in cosmetics and dermatology |
| 08/30/2005 | US6936265 Preparations of the w/o emulsion type with an increased water content based on low-viscosity, readily spreadable lipid components, additionally comprising one or more alkylmethicone copolyols and/or alkyldimethicone copolyols |
| 08/30/2005 | US6936044 Method and apparatus for the stimulation of hair growth |
| 08/30/2005 | CA2359559C Microdermabrasion device |
| 08/30/2005 | CA2336968C Quinoline derivatives |
| 08/30/2005 | CA2164060C Lactate dehydrogenase inhibitors in cosmetic compositions |
| 08/30/2005 | CA2136331C New pharmaceutical uses of krill enzymes |
| 08/30/2005 | CA2103887C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 08/27/2005 | CA2491203A1 Topical antibacterial formulations |
| 08/25/2005 | WO2005077900A1 Bicyclic amide derivatives |
| 08/25/2005 | WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both |
| 08/25/2005 | WO2005077400A1 Cysteine rich peptides for improving thiol homeostasis |
| 08/25/2005 | WO2005077380A1 External preparation for treating painful skin wound |
| 08/25/2005 | WO2005077379A1 Remedy for external use for skin and mucosal injuries caused by viral infection |
| 08/25/2005 | WO2005077352A1 Use of 2,5-dihydroxybenzenesulphonic acid in the production of medicaments for the treatment of angiodependent diseases such as cancer and psoriasis |
| 08/25/2005 | US20050187380 Method for treating Th2-mediated disease |
| 08/25/2005 | US20050187285 administering anticholesterol agents to inhibit the induction of major histocompatibilty complex (MHC class II) expression by gamma-inteferon (IFN- gamma); treatment of autoimmune diseases |
| 08/25/2005 | US20050187284 Integrin receptor inhibitors |
| 08/25/2005 | US20050187273 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 08/25/2005 | US20050187264 2-Cyano-N-[4-(methoxymethoxy)phenethyl]-3-(3-pyridyl)-2-propenamide: generic derivatives described in WO 99/05109; asthma; bronchitis; rhinitis; vision defects; antiarthritic agents; antiallergens; sepsis; inflammatory bowel disease; bipolar disordes; schizophrenia; Crohn's disease; degenerative joints |
| 08/25/2005 | US20050187255 Novel curcumin analogues and uses thereof |
| 08/25/2005 | US20050187248 Making 4-((Z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine; desalting an oxime intermediate, reacting with 2,4-dimethyl-3-(4-oxopiperidin-1-ylcarbonyl)pyridine-n-oxide, cyanation, organometallic; scale-up; chemokine receptor 5 (CCR5) |
| 08/25/2005 | US20050187236 Nitrogen-containing aromatic derivatives |
| 08/25/2005 | US20050187228 Derivatives of purine, their preparation process and pharmaceutical compositions containing them |
| 08/25/2005 | US20050187220 Alleviating pain, treating a locomotive disorders, stress, depression, epilepsy, Alzheimer's disease, senile dementia, general cognitive dysfunction, drug and alcohol abuse, hypotension, hypertension, tinnitus, pruritus, defective hearing, anorexia, obesity; chemical synthesis |
| 08/25/2005 | US20050187197 Novel compounds of the N-acylamino amide family, compositions comprising them and uses thereof |
| 08/25/2005 | US20050187188 Methods for the treatment of a traumatic central nervous system injury |
| 08/25/2005 | US20050187185 for tautening skin, in particular for reducing the size of wrinkles in the facial region in a long-lasting manner; comprising crosslinked or uncrosslinked hyaluronic acid associated with heparin |
| 08/25/2005 | US20050187164 Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof |
| 08/25/2005 | US20050186665 Expressed ligand - vascular intercellular signaling molecule |
| 08/25/2005 | US20050186295 Constituent of the aqueous extract from the radix glycyrrhizae inflatae: treatment of skin disorders |
| 08/25/2005 | US20050186293 Drinkable tea for therapy of dermatitis including eczema characterized in that it contains extracts drawn from one, two or more medicinal herbs selected from Lightyellow Sophora Root, Isatis Leaf, and Terminalia Fruit |
| 08/25/2005 | US20050186288 Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions |
| 08/25/2005 | US20050186280 Carbopol" carboxy vinyl polymer stabilizer; topical formulations for eyes or skin; cream, ointment, gel, patches; drugs, cosmetics |
| 08/25/2005 | US20050186195 Structural or functional components of the creatine kinase/ phosphocreatine system sufficient to prevent, reduce or ameliorate skin damage or skin aging; psoriasis |
| 08/25/2005 | US20050186194 Structural or functional components of the creatine kinase/ phosphocreatine system sufficient to prevent, reduce or ameliorate skin damage or skin aging; psoriasis |
| 08/25/2005 | US20050186158 Use of creatine or creatine compounds for skin preservation |
| 08/25/2005 | DE19903920B4 Sebozyten, Sebozyten-Zellinie und deren Verwendungen Sebocytes, sebocytes cell line and their uses |
| 08/25/2005 | CA2555366A1 Remedy for external use for skin and mucosal injuries caused by viral infection |
| 08/25/2005 | CA2555248A1 Use of 2,5 dihydroxybenzenesulfonic acid, in the manufacturing of medicines, applicable to the treatment of angiodependent diseases |
| 08/25/2005 | CA2554748A1 External preparation for treating painful skin wound |
| 08/25/2005 | CA2554378A1 Bicycloamide derivative |
| 08/24/2005 | EP1566387A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 08/24/2005 | EP1566386A1 A baldness related gene and the polypeptide encoded thereby, and uses thereof |
| 08/24/2005 | EP1566179A2 Agent containing fat (oil) which contains onion extract, the production and use thereof |
| 08/24/2005 | EP1566175A1 Topical preparation comprising at least one aryloxime and bisabolol |
| 08/24/2005 | EP1565547A2 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 08/24/2005 | EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use |
| 08/24/2005 | EP1565197A1 Papaya puree and the use of the same |
| 08/24/2005 | EP1565192A2 Method and compositions for temporarily incapaciting subjets |
| 08/24/2005 | EP1565179A1 Composition comprising a carbamic acid derivative, its use as cosmetic and medicine |
| 08/24/2005 | EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 08/24/2005 | EP1565158A1 Oxazolidinones for cosmetic and pharmaceutical use in skin pathologies |
| 08/24/2005 | EP1565150A1 Composition for hair care or eyelashes containing a pyrazol-carboxamide, its use for stimulating hair and eyelash growth and/or for preventing loss thereof |
| 08/24/2005 | EP1401841B1 Substituted 1-oxa-2,8-diaza-spiro 4,5]dec-2-ene derivatives as medicaments for the treatment of pain |
| 08/24/2005 | EP1392307B1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 08/24/2005 | EP1353912B1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 08/24/2005 | EP1343789B1 Tricyclic derivatives of indole with antiangiogenic activity |
| 08/24/2005 | EP1286975B1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists |
| 08/24/2005 | EP1263742B1 Oxazolidinone thioamides with piperazine amide substituents |
| 08/24/2005 | EP1190248B1 Screening methods for compounds which affect melanogenesis |
| 08/24/2005 | EP1144394B1 1-heterocycle substituted diarylamines |
| 08/24/2005 | EP1143925B1 Topical composition comprising n-acetylglucosamine |
| 08/24/2005 | EP1077675B1 Compositions for the treatment of acne |
| 08/24/2005 | EP1019075B1 Beta 2-adrenergic receptor agonists |
| 08/24/2005 | EP1001770B1 Tazarotene and uvb phototherapy treatment for psoriasis |
| 08/24/2005 | EP0996438B1 Use of cis-6-hexadecenoic acid esters for treating psoriasis, allergies, auto-immune disorders and dry, sensitive skin |
| 08/24/2005 | EP0979654B1 Activated vitamin d 3 emulsion-type lotions |
| 08/24/2005 | EP0792370B1 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
| 08/24/2005 | EP0662132B1 Self-assembling recombinant hpv16 papillomavirus capsid proteins |
| 08/24/2005 | CN1659288A Method to inhibit cell growth using oligonucleotides |
| 08/24/2005 | CN1659171A Specific cyclolignans for treating insulin-like growth factor-1 receptor dependent diseases |
| 08/24/2005 | CN1659169A Riboflavin derivative and its preparation method and uses |
| 08/24/2005 | CN1659161A Piperidine derivatives having CCR3 antagonism |
| 08/24/2005 | CN1659150A Quinazoline derivative and medicine |
| 08/24/2005 | CN1659148A Aryloximes |
| 08/24/2005 | CN1659147A Pyridazine derivatives |
| 08/24/2005 | CN1659144A Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 08/24/2005 | CN1659132A Novel ligand inhibitors of the rar receptors, process for preparing same and therapeutic/cosmetic applications thereof |
| 08/24/2005 | CN1658901A Methods for treating TWEAK-related conditions |
| 08/24/2005 | CN1658895A Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
| 08/24/2005 | CN1658893A G-type peptides to ameliorate atherosclerosis |
| 08/24/2005 | CN1658888A Quaternised ammonium cyclodextrin compounds |
| 08/24/2005 | CN1658886A Hormone replacement therapy |
| 08/24/2005 | CN1658885A Hormone replacement therapy |
| 08/24/2005 | CN1658877A Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 08/24/2005 | CN1658872A Antiallergic |
| 08/24/2005 | CN1658866A Tri-substituted heteroaryls and methods of making and using the same |
| 08/24/2005 | CN1658864A Stabilized ascorbic acid derivatives |
| 08/24/2005 | CN1658863A Severe sepsis preventive therapeutic agent |
| 08/24/2005 | CN1658848A Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds |
| 08/24/2005 | CN1657539A Human connective tissue growth factor mutant protein and its application |
| 08/24/2005 | CN1657072A Special effect medicine for treating split of hand and foot break (rhagades of hand and foot) and tinea of hand and foot |
| 08/24/2005 | CN1657068A Chinese-medicinal plaster for external wound |
| 08/24/2005 | CN1657067A Chinese medicine for treating psoriasis |
| 08/24/2005 | CN1216056C Sulfamato hydroxamic acid metalloprotease inhibitor |